APP and Alzheimer disease: At 60d and 90d of culture, we subjected organoids from a healthy control (Ctrl) and a familial (fAD) patient (APP duplication, APPDp1-1, reported in Israel et al., 2012) to a number of assays for AD-relevant phenotypes.